Recent Finacing
Recent Raise
OccuRx is a Melbourne-based biopharmaceutical company developing a novel class of anti-fibrotic therapeutics, with a lead compound showing preclinical efficacy in animal models of ocular inflammation and fibrosis.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors